Novartis drops after cholesterol drug fails in late-stage trial Shares of Novartis dropped as much as 3.6% early Monday after it said an experimental drug failed to reduce the risk of cardiovascular e...
AI for Everyone
Novartis drops after cholesterol drug fails in late-stage trial Shares of Novartis dropped as much as 3.6% early Monday after it said an experimental drug failed to reduce the risk of cardiovascular e...